叙述性综述与系统综述对专家癌症试验预测的影响:一项随机试验
该随机试验将结直肠外科专家随机分配阅读叙述性综述或系统综述,评估其对一项正在进行的结直肠癌手术临床试验的预测和伦理评价。阅读叙述性综述的专家更倾向于预测更高的绝对风险降低(58% vs 33%,P=0.018),并在假设伦理审查中更支持试验(48% vs 26%,P=0.039)。结论指出,同一试验的叙述性综述与系统综述可导致不同的判断,提示伦理审查中可能存在未解决的偏倚来源。
要点
- 阅读叙述性综述的专家更可能预测高绝对风险降低(58% vs 33%)。
- 叙述性综述组更倾向于在伦理审查中强烈支持试验(20.0% vs 8.9%)。
- 综述类型可能引入伦理审查中的偏倚,需关注证据来源。
核心结论
- 同一试验的叙述性综述与系统综述导致专家对可能结果和伦理适当性的判断不同。
- 这些差异指向伦理审查中一个潜在的未解决偏倚来源。
研究设计与样本
- 随机试验:结直肠外科专家被随机分配阅读叙述性综述或系统综述。
- 阅读后预测试验结果并在假设伦理审查下评价试验。
主要发现
- 叙述性综述组(n=55)预测更高绝对风险降低的比例为58%,系统综述组(n=56)为33%,P=0.018。
- 平均预测绝对风险降低:叙述性综述组10.6% vs 系统综述组6.6%,平均差4.0% [95%CI: 0.3%, 7.8%]。
- 叙述性综述组在假设伦理审查中更支持试验:48% vs 26%,P=0.039。
- 叙述性综述组20.0% vs 系统综述组8.9%「强烈支持」继续试验。
临床怎么用
- 临床与伦理审查中应意识到综述类型可能影响对试验结果的判断。
- 在评估临床试验时,优先参考系统综述以减少潜在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of the study was to assess the impact of narrative review (NR) vs. systematic review (SR) on expert assessments of a clinical trial. STUDY DESIGN AND SETTING: Experts in colon and rectal surgery were randomized to read an NR or SR for an ongoing clinical trial involving surgery for colorectal cancer. Experts from the United States and Canada completed online or paper surveys between December 2018 and June 2019. After reading the NR or SR, experts predicted the trial's outcome and evaluated the trial under a hypothetical ethical review. RESULTS: Experts who read the NR (n = 55) compared with those who read the SR (n = 56) were more likely to predict a higher absolute risk reduction, 58% vs. 33%, P = 0.018, mean predictions 10.6% vs. 6.6%, mean difference 4.0% [95% confidence interval: 0.3%, 7.8%]. Experts who read the NR were more likely to evaluate the trial more favorably under a hypothetical ethical review, 48% vs. 26%, P = 0.039, 20.0% vs. 8.9% "strongly in favor" of trial being pursued. CONCLUSION: An NR and an SR for the same trial led to different judgments of likely outcomes and ethical appropriateness. These differences point to a potential source of unaddressed bias in ethical review.
引用
- Yu M, Montroy J, Fergusson D, et al. Systematic review and narrative review lead experts to different cancer trial predictions: a randomized trial. J Clin Epidemiol. 2020. PMID: 33346013. doi:10.1016/j.jclinepi.2020.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。